Xu W - Search Results

1

A Lysosome-Targeting Self-Condensation Prodrug-Nanoplatform System for Addressing Drug Resistance of Cancer.

Hou DY, Wang MD, Zhang NY, Xu S, Wang ZJ, Hu XJ, Lv GT, Wang JQ, Lv MY, Yi L, Wang L, Cheng DB, Sun T, Wang H, Xu W. Hou DY, et al. Among authors: xu s, xu w. Nano Lett. 2022 May 25;22(10):3983-3992. doi: 10.1021/acs.nanolett.2c00540. Epub 2022 May 12. Nano Lett. 2022. PMID: 35548949

2

MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways.

Sun P, Wang L, Lu Y, Liu Y, Li L, Yin L, Zhang C, Zhao W, Shen B, Xu W. Sun P, et al. Among authors: xu w. Int J Oncol. 2016 Sep;49(3):1155-63. doi: 10.3892/ijo.2016.3608. Epub 2016 Jul 6. Int J Oncol. 2016. PMID: 27572273

3

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.

Chen G, Wang Y, Wang L, Xu W. Chen G, et al. Among authors: xu w. Oncotarget. 2017 Jan 17;8(3):5268-5280. doi: 10.18632/oncotarget.14134. Oncotarget. 2017. PMID: 28029655 Free PMC article.

4

Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.

Wang J, Fang R, Wang L, Chen G, Wang H, Wang Z, Zhao D, Pavlov VN, Kabirov I, Wang Z, Guo P, Peng L, Xu W. Wang J, et al. Among authors: xu w. Cell Physiol Biochem. 2018;47(4):1565-1577. doi: 10.1159/000490875. Epub 2018 Jun 27. Cell Physiol Biochem. 2018. PMID: 29949785 Free article. Clinical Trial.

5

High-Performance Identification of Human Bladder Cancer Using a Signal Self-Amplifiable Photoacoustic Nanoprobe.

Zhang D, Wang Z, Wang L, Wang Z, Wang H, Li G, Qiao ZY, Xu W, Wang H. Zhang D, et al. Among authors: xu w. ACS Appl Mater Interfaces. 2018 Aug 29;10(34):28331-28339. doi: 10.1021/acsami.8b08357. Epub 2018 Aug 14. ACS Appl Mater Interfaces. 2018. PMID: 29989788

6

A gel system for single instillation of non-muscle-invasive bladder Cancer: A "divide-and-rule" strategy.

Guo P, Shang W, Peng L, Wang L, Wang H, Han Z, Jiang H, Tian J, Wang K, Xu W. Guo P, et al. Among authors: xu w. J Control Release. 2018 Sep 10;285:46-55. doi: 10.1016/j.jconrel.2018.06.036. Epub 2018 Jul 2. J Control Release. 2018. PMID: 30008370

7

Addressable Peptide Self-Assembly on the Cancer Cell Membrane for Sensitizing Chemotherapy of Renal Cell Carcinoma.

Wang Z, An HW, Hou D, Wang M, Zeng X, Zheng R, Wang L, Wang K, Wang H, Xu W. Wang Z, et al. Among authors: xu w. Adv Mater. 2019 Mar;31(11):e1807175. doi: 10.1002/adma.201807175. Epub 2019 Jan 21. Adv Mater. 2019. PMID: 30663139

8

Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.

Peng Q, Wang L, Zhao D, Lv Y, Wang H, Chen G, Wang J, Xu W. Peng Q, et al. Among authors: xu w. J Cancer. 2019 Jan 29;10(5):1237-1251. doi: 10.7150/jca.28662. eCollection 2019. J Cancer. 2019. PMID: 30854133 Free PMC article.

9

CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.

Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q, Wang H, Fang R, Chen G, Wang Z, Wang K, Li G, Yang Y, Wang Z, Guo P, Peng L, Hou D, Xu W. Wang L, et al. Among authors: xu w. Mol Cancer. 2019 Apr 11;18(1):86. doi: 10.1186/s12943-019-0997-z. Mol Cancer. 2019. PMID: 30975145 Free PMC article.

10

Endogenous Reactive Oxygen Species-Triggered Morphology Transformation for Enhanced Cooperative Interaction with Mitochondria.

Cheng DB, Zhang XH, Gao YJ, Ji L, Hou D, Wang Z, Xu W, Qiao ZY, Wang H. Cheng DB, et al. Among authors: xu w. J Am Chem Soc. 2019 May 8;141(18):7235-7239. doi: 10.1021/jacs.8b07727. Epub 2019 Apr 26. J Am Chem Soc. 2019. PMID: 31010287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,296 results

Search Page

Filters